Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Beyond Air Inc is a medical devices business based in the US. Beyond Air shares (XAIR) are listed on the NASDAQ and all prices are listed in US Dollars. Beyond Air employs 62 staff and has a trailing 12-month revenue of around $145,190.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $7.50 |
|---|---|
| 52-week range | $4.79 - $16.41 |
| 50-day moving average | $9.45 |
| 200-day moving average | $7.76 |
| Wall St. target price | $18.60 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.21 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $7.5 from 2022-09-29
| 1 week (2022-09-23) | -7.98% |
|---|---|
| 1 month (2022-09-01) | -19.27% |
| 3 months (2022-07-01) | 1.08% |
| 6 months (2022-04-01) | 12.44% |
| 1 year (2021-10-01) | -29.31% |
|---|---|
| 2 years (2020-10-01) | 37.11% |
| 3 years (2019-10-01) | 61.64% |
| 5 years (2017-09-29) | 44.79% |
| Revenue TTM | $145,190 |
|---|---|
| Gross profit TTM | $873,190 |
| Return on assets TTM | -32.21% |
| Return on equity TTM | -93.45% |
| Profit margin | 0% |
| Book value | $2.21 |
| Market capitalisation | $234 million |
TTM: trailing 12 months
We're not expecting Beyond Air to pay a dividend over the next 12 months.
Beyond Air's shares were split on a 1:100 basis on 10 January 2017. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Beyond Air shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Beyond Air shares which in turn could have impacted Beyond Air's share price.
Over the last 12 months, Beyond Air's shares have ranged in value from as little as $4.785 up to $16.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Beyond Air's is -0.2473. This would suggest that Beyond Air's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Beyond Air has bucked the trend.
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc.
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
Our list of 10 dividend stocks to watch in 2022.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.